期刊文献+

帕金森病患者下尿路功能障碍治疗研究进展 被引量:3

Treatment for Lower Urinary Tract Dysfunction in Patients with Parkinson's Disease
下载PDF
导出
摘要 帕金森病(Parkinson’s disease,PD)是一种渐进的中枢神经系统退行性疾病。尽管帕金森病是以运动症状为主要特征,但其非运动症状也逐渐受到重视。帕金森病患者常常会出现下尿路功能障碍,主要症状包括尿急、尿频、夜尿症、急迫性尿失禁等,严重影响患者的生活质量。该文综述了目前临床常用的治疗策略以及一些潜在的治疗方法。 Parkinson's disease is a progressive degenerative disorder of the central nervous system. Although motor symptoms are a predominant feature of the condition, non-motor symptoms have also been recognized. Lower urinary tract dysfunction is frequently present in patients affected with Parkinson's disease. Symptoms such as urgency, frequency,nocturia and urge incontinence significantly impact the patient's quality of life. We present an overview of current and prospective treatment strategies. These treatments might be beneficial in improving the patients' quality of life.
出处 《神经药理学报》 2014年第4期36-41,共6页 Acta Neuropharmacologica
基金 河北省教育厅项目(No.Z2012014) 河北北方学院校级课题(No.Q2013028)
关键词 帕金森病 治疗 下尿路 膀胱 尿道 功能障碍 Parkinson's disease treatment lower urinary tract bladder urethra dysfunction
  • 相关文献

参考文献33

  • 1Jain S. Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord. 2011, 17(2):77-83.
  • 2Badri AV, Purohit RS, Skenazy J, et al. A review of lower urinary tract symptoms in patients with Parkinson's disease. Curr Urol Rep. 2014, 15(9):435-443.
  • 3Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008, 9(6):453-466.
  • 4Aranda B, Cramer P. Effect of apomorphine and L-dopa on the parkinsonian bladder. Neurourol Urodyn. 1993, 12(3): 203-209.
  • 5Winge K, Werdelin LM, Nielsen KK, et al. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol Urodyn. 2004, 23(7):689-696.
  • 6Kuno S, Mizuta E, Yamasaki S, et al. Effects of pergolide on nocturia in Parkinson’s disease: three female cases selected from over 400 patients. Parkinsonism Relat Disord. 2004, 10(3):181-187.
  • 7Fitzmaurice H, Fowler CJ, Rickards D, et al. Micturition disturbance in Parkinson’s disease. Br J Urol. 1985; 57(6):652-656.
  • 8Obeso JA, Olanow CW, Nutt JG. Levodopa motor complications in Parkinson’s disease. Trend Neurosci. 2000; 23(10 Suppl): S2-S7.
  • 9孙颖浩.α1受体阻滞剂治疗良性前列腺增生研究进展[J].中华男科学杂志,2004,10(7):483-485. 被引量:24
  • 10Gomes CM, Sammour ZM, Bessa Junior Jd, et al. Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease. Clinics (Sao Paulo). 2014, 69(12):817-822.

二级参考文献94

共引文献67

同被引文献23

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部